This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of eye and adnexa
C3_EYE_ADNEXA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
298 |
4. Check minimum number of eventsNone |
298 |
5. Include endpointsNone |
298 |
6. Filter based on genotype QC (FinnGen only) |
293 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of eye and adnexa
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of eye and adnexa, including Hilmo
- Malignant neoplasm of eye, brain and central nervous system
- Solid cancers, helper endpoint
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 293 | 133 | 160 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 60.31 | 58.24 | 62.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 298
- Matched controls
- 2980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XCD10
NOMESCO Finland
Electrophysiological examination of eye
82.1
256.9
145
34
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
186.7
159
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
161.6
140
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
161.6
140
*
WX140
NOMESCO Finland
Parabulbar anesthesy
27.2
153.8
121
73
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
139.9
123
*
XCK10
NOMESCO Finland
Photography of fundus of eye
17.2
137.2
153
172
H02AB02
ATC
dexamethasone; systemic
59.8
101.7
58
12
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
13.6
92.8
105
115
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
91.5
83
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
171.7
85.2
86
7
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
82.2
75
*
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
76.4
70
*
130
Kela drug reimbursment
Malignant tumour
+∞
76.4
70
*
Z3229
NOMESCO Finland
Other healthcare associate professional
8.7
62.1
97
156
JN4BD
NOMESCO Finland
Extensive body CT
12.7
59.4
64
63
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
59.4
55
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
7.9
58.4
102
185
WX002
NOMESCO Finland
Sedation and analgesia
6.6
57.4
137
339
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
7.6
55.2
98
180
Z51.5
ICD-10 Finland
Palliative care
13.5
53.3
54
48
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
10.0
52.1
67
84
A03FA01
ATC
metoclopramide; systemic, rectal
7.0
51.6
100
200
A04AA01
ATC
ondansetron; systemic, rectal
17.0
50.4
44
30
ZXD10
NOMESCO Finland
Scheduled procedure
5.6
46.7
196
763
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
138.9
45.2
47
*
ZXA05
NOMESCO Finland
Left side
5.0
42.5
151
506
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
40.5
38
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
40.5
38
*
XW000
NOMESCO Finland
Bone marrow biopsy
16.4
39.7
35
24
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
39.5
37
*
Z2221
NOMESCO Finland
Medical doctor
4.8
39.2
142
477
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
15.1
38.0
35
26
WF002
NOMESCO Finland
Radical radiotherapy
148.9
37.7
39
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
403.7
36.8
36
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
36.2
34
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
7.8
33.9
52
79
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
55.8
33.4
39
8
CFA20
NOMESCO Finland
Biopsy of conjunctiva
95.7
31.5
34
*
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
30.8
29
*
ZXE00
NOMESCO Finland
One hour or less
4.0
30.5
171
757
WZC00
NOMESCO Finland
Treatment plan or consultation
4.0
29.8
126
459
9510/3-C69.2
ICD-O-3
Retinoblastoma, NOS, of retina
+∞
29.7
28
*
CAA30
NOMESCO Finland
Biopsy of orbit
+∞
29.7
28
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
28.6
27
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
28.6
27
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.1
28.3
105
347
S01ED51
ATC
timolol, combinations; ophthalmic
5.4
27.7
63
141
ZXA00
NOMESCO Finland
Right side
3.8
27.5
136
545
XX3DW
NOMESCO Finland
Time consuming IT work
8.0
27.4
40
57
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
29.3
25.5
34
13
CF2S4
NOMESCO Finland
Photography of conjunctiva
+∞
25.4
24
*
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
141.9
25.0
26
*
N02AA05
ATC
oxycodone; systemic
4.1
24.9
85
262
ZXE10
NOMESCO Finland
More than one and less than three hours
3.5
24.7
151
683
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
24.3
23
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
23.2
22
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
23.2
22
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
19.0
22.4
34
20
JN4AD
NOMESCO Finland
Body CT examination
6.2
22.2
41
75
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
22.2
21
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
22.2
21
*
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
21.1
20
*
L03AA13
ATC
pegfilgrastim; parenteral
112.6
19.8
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
112.6
19.8
21
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
112.6
19.8
21
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.1
19.4
27
36
S01ED01
ATC
timolol; ophthalmic
6.9
19.2
31
49
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
59.1
19.2
22
*
JN4CD
NOMESCO Finland
Very extensive body CT
18.7
19.1
29
17
L01AX03
ATC
temozolomide; systemic
+∞
19.0
18
*
C69.21
ICD-10 Finland
Retina
+∞
19.0
18
*
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
41.3
18.8
23
6
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
202.2
18.8
19
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
190.9
17.7
18
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
16.8
16
*
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
179.6
16.7
17
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.8
16.5
166
934
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.9
16.4
39
89
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
15.7
16.2
26
18
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
20.7
15.8
23
12
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
15.8
15
*
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
15.8
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.8
15
*
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
15.8
15
*
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
15.8
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.8
15
*
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
15.8
15
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
15.8
15
*
CDC00
NOMESCO Finland
Enucleation of eye
168.5
15.6
16
*
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
168.5
15.6
16
*
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
168.5
15.6
16
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
15.5
97
424
H26.2
ICD-10 Finland
Complicated cataract
21.5
15.3
22
11
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.0
15.1
28
51
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
19.7
14.9
22
12
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
+∞
14.7
14
*
180
Kela drug reimbursment
Interferon alfa
+∞
14.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
14.7
14
*
C69.20
ICD-10 Finland
Retina
+∞
14.7
14
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
157.4
14.6
15
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
14.4
163
950
Z3231
NOMESCO Finland
Registered nurse
2.7
14.4
107
509
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.5
13.9
145
811
Z97.0
ICD-10 Finland
Presence of artificial eye
78.9
13.7
15
*
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
13.6
13
*
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
13.6
13
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
13.6
13
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
146.4
13.6
14
*
3779
FHL
Other operations in this group include disc removal
146.4
13.6
14
*
CD2S4
NOMESCO Finland
Photography of eye
42.1
13.3
16
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.1
13.3
26
28
JN6AD
NOMESCO Finland
CT of torso and neck
29.9
13.1
17
6
CBA10
NOMESCO Finland
Biopsy of eyelid
25.6
12.6
17
7
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.6
12
*
116
Kela drug reimbursment
Prostate cancer
+∞
12.6
12
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
12.6
12
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
12.6
12
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
12.5
53
183
CA1ME
NOMESCO Finland
Ultrasound oculometry
28.0
12.2
16
6
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.5
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.5
11
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
11.5
11
*
CAW99
NOMESCO Finland
Other operation on orbit
+∞
11.5
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
124.6
11.5
12
*
PJA12
NOMESCO Finland
Sentinel node biopsy
124.6
11.5
12
*
WZC30
NOMESCO Finland
Teaching
3.1
11.3
53
194
WX142
NOMESCO Finland
Sub-tenon anesthesy
26.2
11.2
15
6
ZX120
NOMESCO Finland
Intravenous
3.9
11.1
35
99
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
10.5
10
*
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
10.5
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.5
10
*
CH2S4
NOMESCO Finland
Photography of iris
+∞
10.5
10
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
10.5
10
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
33.8
10.4
13
*
L02AE02
ATC
leuprorelin; implant, parenteral
41.6
10.0
12
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
27.1
9.9
13
5
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.5
9.8
25
60
ZXE20
NOMESCO Finland
More than three and less than five hours
2.9
9.7
51
199
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
18.3
9.5
14
8
A06AH03
ATC
naloxegol; oral
31.1
9.5
12
*
L03AA02
ATC
filgrastim; parenteral
103.2
9.5
10
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
103.2
9.5
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
9.4
9
*
C69.29
ICD-10 Finland
Retina
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
C69.0
ICD-10 Finland
Malignant neoplasm: Conjunctiva
+∞
9.4
9
*
C69.2
ICD-10 Finland
Malignant neoplasm: Retina
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
JJ1AQ
NOMESCO Finland
Liver SPECT with low dose CT
+∞
9.4
9
*
8720/3-C69.0
ICD-O-3
Malignant melanoma, NOS, of conjunctiva
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
C69.63
ICD-10 Finland
Malignant tumor of orbital carcinoma
+∞
9.4
9
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
9.4
9
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
9.4
9
*
1905A
ICD-9 Finland
Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]
+∞
9.4
9
*
19003
ICD-8 Finland
Malignant neoplasm of eye, Retinae
+∞
9.4
9
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.7
9.2
19
23
ZXA10
NOMESCO Finland
Bilateral
2.4
9.2
80
399
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.9
9.0
20
43
Z31.5
ICD-10 Finland
Genetic counselling
5.0
8.7
19
40
H43.1
ICD-10 Finland
Vitreous haemorrhage
7.3
8.7
20
29
HA1AA
NOMESCO Finland
X-ray mammography
8.3
8.5
18
23
F74
ICPC
Neoplasm of eye/adnexa
+∞
8.4
8
*
Y77
ICPC
Malignant neoplasm prostate
+∞
8.4
8
*
9591/3-C69.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
8.4
8
*
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
CA1AD
NOMESCO Finland
Orbita CT
+∞
8.4
8
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
8.4
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
H05.2
ICD-10 Finland
Exophthalmic conditions
25.8
7.6
10
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
82.1
7.5
8
*
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
82.1
7.5
8
*
3102
FHL
Enucleation
82.1
7.5
8
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.7
7.4
15
18
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
7.3
7
*
C69.91
ICD-10 Finland
Malignant tumor in unspecified localization in the eye retinoblastoma
+∞
7.3
7
*
H05.9
ICD-10 Finland
Disorder of orbit, unspecified
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
7.3
7
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.3
7
*
CFD10
NOMESCO Finland
Repair of conjunctiva
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
H16.0
ICD-10 Finland
Corneal ulcer
3.8
7.3
23
65
CBB30
NOMESCO Finland
Excision of lesion of eyelid
7.6
7.3
16
22
XCK00
NOMESCO Finland
Perimetry
3.2
7.1
29
97
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
7.1
57
272
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.6
7.0
17
27
XCD20
NOMESCO Finland
Photoangiography of eye
7.8
7.0
15
20
H01.0
ICD-10 Finland
Blepharitis
3.4
6.9
25
78
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
17.2
6.8
10
6
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
41.0
6.8
8
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
6.1
6.7
17
29
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.6
6.6
18
34
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
71.3
6.4
7
*
H11.9
ICD-10 Finland
Disorder of conjunctiva, unspecified
71.3
6.4
7
*
H02.4
ICD-10 Finland
Ptosis of eyelid
4.2
6.4
17
42
ZX112
NOMESCO Finland
Subcutaneous
11.4
6.3
11
10
S01EE01
ATC
latanoprost; ophthalmic
2.9
6.3
31
116
WW500
NOMESCO Finland
Blood transfusion
7.3
6.3
14
20
H05.0
ICD-10 Finland
Acute inflammation of orbit
+∞
6.3
6
*
CKE40
NOMESCO Finland
Transpupillary photocoagulation of lesion of retina
+∞
6.3
6
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
ZZL00
NOMESCO Finland
Free graft of amniotic membrane
+∞
6.3
6
*
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
+∞
6.3
6
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
6.3
6
*
QX2AN
NOMESCO Finland
Other soft tissue tumour isotope imaging
+∞
6.3
6
*
C69.90
ICD-10 Finland
Malignant tumor in unspecified localization in eye without histology
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C69.4
ICD-10 Finland
Malignant neoplasm: Ciliary body
+∞
6.3
6
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
6.3
6
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.2
6.3
63
330
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.3
6.3
8
*
Z2446
NOMESCO Finland
Social worker
3.0
6.3
29
105
XCH00
NOMESCO Finland
Eye pressure measurement
3.2
6.2
25
83
S01EA03
ATC
apraclonidine; ophthalmic
8.9
6.1
12
14
S01EA05
ATC
brimonidine; ophthalmic
5.8
6.1
16
29
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.3
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
168
684
4.34
34.98
5.7
3.0
32.17
33.09
u/l
0.14
161
648
53
119
5.20
23.01
2.6
1.4
3.18
2.62
ug/l
0.49
39
97
33
51
7.15
20.93
1.8
1.7
19.54
112.46
u/ml
0.45
28
39
191
1085
3.12
19.78
11.4
3.9
13.50
12.05
umol/l
0.51
186
1016
196
1221
2.77
15.54
16.5
6.3
3.83
4.24
e9/l
2.27
178
1071
240
1694
3.14
14.44
14.6
5.3
90.38
78.38
u/l
2.10
228
1550
159
947
2.46
13.02
6.1
3.8
34.74
35.72
g/l
1.26
150
872
173
1116
2.31
11.22
8.3
6.2
1.21
1.21
mmol/l
0.39
146
959
19
22
9.14
9.44
1.8
1.8
3.70
170.64
u/ml
0.48
19
22
156
1014
2.13
9.33
7.2
5.9
1.21
1.21
mmol/l
0.18
149
902
8
0
+∞
8.37
1.3
0.0
—
—
—
0
0
117
710
2.07
8.13
6.6
2.1
2.36
2.36
mmol/l
0.10
106
591
18
25
7.59
8.09
1.3
1.2
—
—
—
0
0
14
14
10.43
7.61
1.9
2.1
789.79
590.57
e6/l
0.55
14
14
6
0
+∞
6.27
1.0
0.0
8.95
—
%
—
6
0
6
0
+∞
6.27
1.3
0.0
22.30
—
%
—
6
0
6
0
+∞
6.27
1.3
0.0
36.02
—
%
—
6
0
180
1368
1.80
5.62
5.5
4.7
6.70
6.80
mmol/l
0.29
174
1273
73
422
1.97
5.51
4.9
2.1
2.46
2.44
mmol/l
0.73
66
355
48
238
2.21
5.43
4.8
2.5
13.82
6.34
umol/l
0.80
40
204
95
606
1.83
5.29
2.3
2.4
4615.45
8969.19
umol/l
0.42
84
526
5
0
+∞
5.22
2.4
0.0
0.06
—
ug/l
—
5
0
16
36
4.64
5.13
3.4
3.1
52.87
59.00
%
0.63
16
36
77
467
1.87
5.00
3.3
2.2
—
—
—
0
0
149
1114
1.68
4.58
13.3
16.0
1.25
1.37
inr
0.74
45
307
15
36
4.33
4.58
2.7
2.6
4.50
4.63
e9/l
0.06
15
36
130
947
1.66
4.36
3.2
2.4
—
—
—
0
0
52
294
1.93
4.13
2.1
2.3
22.17
23.62
%
0.35
47
257
104
737
1.63
3.77
3.8
2.2
65.30
62.58
u/l
0.12
99
680
38
212
1.91
3.14
4.3
1.6
364.92
371.28
nmol/l
0.08
38
194
17
70
2.51
2.93
2.1
3.1
—
—
—
0
0
14
52
2.78
2.93
3.8
2.0
46.50
32.67
umol/l
1.60
14
45
7
13
5.48
2.88
1.1
1.3
—
—
—
0
0
5
6
8.45
2.76
1.0
1.2
—
—
—
0
0
6
10
6.10
2.71
1.2
1.4
21.12
11.14
ug/l
—
6
10
11
35
3.22
2.67
1.3
1.6
—
—
—
0
0
5
7
7.24
2.56
1.0
1.6
—
—
—
0
0
86
632
1.51
2.53
3.0
3.0
0.12
0.38
e6/l
3.19
65
478
10
32
3.20
2.46
1.2
1.6
—
—
—
0
0
6
13
4.69
2.28
2.3
2.2
—
—
—
0
0
12
48
2.56
2.21
3.6
1.8
—
—
—
0
0
33
199
1.74
2.16
2.1
2.1
41.81
33.68
u/l
0.21
27
163
6
14
4.35
2.16
2.2
3.4
—
—
—
0
0
104
818
1.42
2.11
3.4
3.1
—
—
—
0
0
197
2189
0.70
2.09
5.9
6.2
39.67
40.50
mmol/mol
0.67
187
2032
249
2286
1.54
2.05
21.9
13.1
26.05
23.04
mg/l
0.70
216
1748
18
90
2.06
2.05
1.2
1.6
—
163.33
—
0
6
11
44
2.56
2.03
1.2
1.3
—
—
—
0
0
11
44
2.56
2.03
1.2
1.3
—
—
—
0
0
205
2255
0.71
1.96
4.2
4.6
1.41
1.46
mmol/l
0.81
195
2062
208
2279
0.71
1.90
4.4
4.7
4.56
4.54
mmol/l
0.10
196
2096
6
17
3.58
1.84
1.0
1.0
—
—
—
0
0
35
225
1.63
1.84
2.5
3.0
—
—
—
0
0
53
379
1.48
1.76
1.5
1.7
—
—
—
0
0
40
270
1.56
1.73
4.6
8.0
0.92
1.60
mmol/l
0.61
34
212
6
19
3.20
1.67
1.0
1.4
—
—
—
0
0
82
1022
0.73
1.66
2.2
2.0
95.52
94.70
pmol/l
0.05
43
519
216
2335
0.73
1.62
4.8
5.2
2.70
2.66
mmol/l
0.29
204
2138
53
386
1.45
1.61
2.6
2.7
0.93
1.20
e6/l
0.27
31
225
10
43
2.37
1.60
1.1
1.7
—
—
—
0
0
49
355
1.46
1.53
2.7
3.0
0.40
2.54
e6/l
3.88
27
194
201
2185
0.75
1.45
3.9
4.2
1.38
1.27
mmol/l
1.20
191
1982
27
175
1.60
1.40
2.6
2.2
55.40
61.23
ml/min/173m2
—
10
73
161
1424
1.28
1.34
4.3
3.1
78.07
47.85
u/l
1.67
150
1321
6
24
2.53
1.31
1.2
1.1
—
—
—
0
0
13
69
1.92
1.30
12.3
4.7
1.05
1.57
mg/l
4.12
13
62
129
1115
1.28
1.27
3.5
3.7
0.00
0.00
estimate
-0.00
24
193
6
25
2.43
1.25
2.0
3.6
—
—
—
0
0
212
2273
0.77
1.24
4.6
4.7
5.94
6.04
mmol/l
0.64
191
2050
5
19
2.66
1.22
2.0
1.8
—
—
—
0
0
10
51
1.99
1.12
1.2
1.4
—
—
—
0
0
256
2433
1.37
1.09
18.0
9.0
29.09
25.55
u/l
2.27
246
2336
5
21
2.40
1.09
2.2
1.7
—
—
—
0
0
41
535
0.73
1.08
1.7
1.8
579.85
424.62
pmol/l
0.63
34
439
38
282
1.40
1.07
6.4
5.8
1.09
1.07
mmol/l
0.10
33
253
6
27
2.25
0.94
1.0
1.0
—
—
—
0
0
8
45
1.80
0.85
1.1
1.2
—
—
—
0
0
126
1127
1.20
0.83
4.7
5.1
0.00
0.00
estimate
-0.00
23
173
127
1137
1.20
0.83
3.6
3.7
0.00
0.00
estimate
-0.00
24
172
35
270
1.34
0.81
1.4
1.8
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
186
1732
1.20
0.77
4.7
4.1
12.17
11.65
mm/h
0.20
172
1580
19
133
1.46
0.75
2.0
2.9
24.31
25.23
mmol/l
0.51
19
128
29
375
0.75
0.74
1.3
1.3
35.83
42.02
iu/ml
0.13
12
115
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
68
1.64
0.72
1.5
9.2
0.52
0.37
u/ml
—
6
35
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
9
58
1.57
0.70
1.1
1.1
0.00
0.00
g/l
—
9
53
7
41
1.72
0.70
1.3
1.5
—
—
—
0
0
5
27
1.87
0.68
1.0
1.4
—
—
—
0
0
223
2123
1.20
0.67
20.8
11.7
81.07
76.34
ml/min/173m2
3.13
195
1696
34
270
1.29
0.66
1.5
1.8
—
—
—
0
0
10
62
1.63
0.66
1.2
1.3
—
—
—
0
0
28
356
0.76
0.65
1.4
1.3
43.76
13.10
u/ml
—
9
132
55
465
1.22
0.64
2.3
2.1
1.44
1.22
mg/l
0.22
48
365
70
801
0.84
0.63
4.1
3.8
15.28
7.89
mg/mmol
0.55
45
501
8
49
1.65
0.62
1.1
1.1
—
—
—
0
0
8
50
1.62
0.62
1.3
1.4
—
—
—
0
0
5
30
1.68
0.61
1.2
1.5
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
178.37
—
0
21
69
601
1.19
0.60
3.6
3.9
0.00
0.02
estimate
0.50
21
175
8
52
1.55
0.60
1.3
2.0
—
—
—
0
0
7
115
0.60
0.59
1.1
1.3
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
8
54
1.49
0.57
1.0
1.3
—
—
—
0
0
20
150
1.36
0.57
1.7
1.6
—
—
—
0
0
6
36
1.68
0.57
1.2
1.7
—
—
—
0
0
5
88
0.56
0.57
2.0
1.8
3.07
2.50
mg/l
—
5
59
13
90
1.46
0.56
1.6
1.6
—
—
—
0
0
12
82
1.48
0.55
1.5
1.5
—
—
—
0
0
9
60
1.52
0.55
1.1
1.1
0.00
0.00
g/l
—
9
53
30
243
1.26
0.52
8.5
3.6
2.47
1.91
mmol/l
0.44
25
198
15
109
1.40
0.52
2.8
8.6
1.21
1.65
%
1.69
15
104
24
189
1.29
0.51
7.7
6.4
1.21
1.47
mmol/l
1.04
24
183
12
167
0.71
0.50
1.4
1.8
—
—
—
0
0
18
136
1.34
0.50
1.6
1.5
—
—
—
0
0
29
235
1.26
0.50
1.1
1.4
—
—
—
0
0
58
506
1.18
0.50
4.6
4.1
548.04
346.10
ng/l
0.15
51
415
43
503
0.83
0.50
1.8
1.8
1107.37
1223.22
nmol/l
0.42
33
383
12
84
1.45
0.50
1.2
1.1
10.25
10.82
g/l
0.16
12
69
7
47
1.50
0.48
1.1
1.4
—
—
—
0
0
13
94
1.40
0.46
1.2
1.2
7.75
7.58
g/l
0.16
13
79
13
94
1.40
0.46
1.2
1.2
—
—
—
0
0
39
457
0.83
0.46
1.2
1.3
0.36
1.57
u/ml
—
7
111
65
729
0.86
0.46
4.0
3.8
24.45
24.56
%
0.02
40
345
203
2112
0.88
0.45
5.4
4.5
1.80
1.95
mu/l
1.38
188
1904
44
508
0.84
0.45
2.9
2.6
0.96
0.78
ug/l
0.53
33
336
82
900
0.88
0.43
4.9
3.9
2.73
2.05
ug/l
1.18
75
799
247
2401
1.17
0.43
23.9
16.1
139.38
139.76
mmol/l
1.47
239
2330
5
32
1.57
0.42
1.2
1.6
—
—
—
0
0
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
5
32
1.57
0.42
1.2
1.6
—
—
—
0
0
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
19
150
1.28
0.41
1.5
1.6
—
—
—
0
0
15
115
1.32
0.39
5.8
6.9
25.29
24.82
mmol/l
0.45
15
108
0
19
0.00
0.39
0.0
1.0
—
543.21
—
0
14
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
41.95
—
0
14
9
66
1.37
0.38
1.1
1.1
0.00
0.08
g/l
—
9
59
30
253
1.21
0.38
1.8
2.4
5.29
6.87
ug/l
0.34
24
219
29
244
1.21
0.38
8.7
3.6
5.54
5.75
kpa
0.55
29
235
25
208
1.22
0.36
9.5
3.2
4.59
4.45
kpa
0.13
25
199
247
2410
1.15
0.35
23.9
16.2
4.01
4.00
mmol/l
0.09
238
2334
6
43
1.40
0.35
1.2
1.4
—
—
—
0
0
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
105
980
1.11
0.35
4.1
3.7
22.24
40.82
ng/l
3.07
83
715
52
579
0.88
0.34
2.3
2.2
2.98
3.03
mg/l
0.06
52
496
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
12
94
1.29
0.28
1.2
1.2
3.61
3.77
g/l
0.24
12
79
177
1712
1.08
0.25
4.7
3.7
14.89
14.88
pmol/l
0.02
164
1526
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.8
—
13.72
—
0
12
5
43
1.17
0.21
1.4
2.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
122
1264
0.94
0.18
2.4
2.7
—
—
—
0
0
5
67
0.74
0.17
1.8
1.6
—
—
—
0
0
83
796
1.06
0.14
3.5
3.3
1091.67
1495.57
ng/l
0.86
71
676
256
2535
1.07
0.12
32.2
19.3
39.98
40.17
%
0.19
239
2362
256
2535
1.07
0.12
32.1
19.2
239.11
243.68
e9/l
0.47
247
2474
94
912
1.04
0.10
2.5
2.3
81.30
77.57
nmol/l
0.55
86
800
256
2538
1.06
0.10
32.1
19.2
4.44
4.50
e12/l
1.20
247
2464
33
311
1.07
0.09
1.3
1.5
—
—
—
0
0
256
2539
1.06
0.09
32.4
19.3
133.90
135.99
g/l
1.45
250
2497
13
116
1.13
0.09
1.4
1.7
—
—
—
0
0
77
750
1.04
0.07
2.6
2.1
129.04
192.65
u/l
1.81
70
699
14
131
1.07
0.03
1.4
1.8
—
—
—
0
0
31
304
1.02
0.00
8.9
6.9
—
—
—
0
0
17
168
1.01
0.00
2.6
8.2
25.49
24.98
mmol/l
0.23
17
161
89
889
1.00
0.00
3.8
3.8
—
—
—
0
0
13
126
1.03
0.00
4.2
2.3
0.75
0.66
%
0.30
13
126
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
7.13
—
0
7
0
7
0.00
0.00
0.0
1.6
—
68.01
—
0
7
0
8
0.00
0.00
0.0
2.9
—
1.26
—
0
8
5
52
0.96
0.00
1.2
1.2
—
3.16
—
0
5
0
7
0.00
0.00
0.0
1.0
—
9.81
—
0
7
5
49
1.02
0.00
1.2
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
-0.00
1.4
1.2
—
—
—
0
0
9
89
1.01
-0.00
1.4
2.2
91.44
320.10
ug/l
—
9
82
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
-0.00
1.1
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_EYE_ADNEXA – Malignant neoplasm of eye and adnexa
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).